WebMabThera was the first therapeutic monoclonal antibody to target cells that have the CD20 marker on their surface. These cells are central to many blood cancers, including common forms of lymphoma and leukaemia. MabThera attacks these cells both directly and together with the body’s immune system. WebMabThera está indicado en combinación con quimioterapia en el tratamiento de pacientes adultos con linfoma no-Hodgkin folicular estadio III-IV que no hayan sido tratados previamente. MabThera está indicado para el tratamiento de mantenimiento en pacientes adultos con linfoma folicular que hayan respondido al tratamiento de inducción.
FICHA TECNICA MABTHERA 500 MG CONCENTRADO PARA …
Webrituximab: [ rĭ-tuk´sĭ-mab ] a monoclonal antibody that binds CD20 antigen ; used as an antineoplastic agent in treatment of B-cell non-Hodgkin's lymphoma positive for that … Web18 feb. 2024 · MABTHERA 500 MG INFUSION is used in the treatment of non-Hodgkin lymphoma (NHL), rheumatoid arthritis, blood cancer (chronic lymphocytic leukemia), … hdp clark phils inc
Mabthera 1400 mg solutie injectabila - Pret 7.184,53 Lei
WebMabThera is a medicine used to treat the following blood cancers and inflammatory conditions: follicular lymphoma and diffuse large B cell non-Hodgkin’s lymphoma (two types of non-Hodgkin’s lymphoma, a blood cancer) chronic lymphocytic leukaemia (CLL, another blood cancer affecting white blood cells) WebMabThera, en association aux glucocorticoïdes, est indiqué pour l'induction de la rémission chez les patients pédiatriques (âgés de ≥ 2 à < 18 ans) atteints de GPA (maladie de Wegener) et de PAM,... Web24 ian. 2024 · MabThera 1400 mg is used to treat Non-Hodgkin’s lymphoma in adults. This is a disease of the lymph tissue (part of the immune system) that affects a type of white … hdpclient_client_for_windows_v1.6.50005.zip